ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.

Velina S Atanasova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.